- Report
- August 2026
- 200 Pages
Global
From €5237EUR$5,850USD£4,496GBP
- Report
- July 2026
- 192 Pages
Global
From €3174EUR$3,545USD£2,725GBP
€3526EUR$3,939USD£3,027GBP
- Report
- July 2026
- 190 Pages
Global
From €3174EUR$3,545USD£2,725GBP
€3526EUR$3,939USD£3,027GBP
- Report
- June 2026
- 189 Pages
Global
From €3174EUR$3,545USD£2,725GBP
€3526EUR$3,939USD£3,027GBP
- Report
- June 2026
- 197 Pages
Global
From €3174EUR$3,545USD£2,725GBP
€3526EUR$3,939USD£3,027GBP
- Report
- January 2026
- 185 Pages
Global
From €3174EUR$3,545USD£2,725GBP
€3526EUR$3,939USD£3,027GBP
- Report
- January 2026
- 188 Pages
Global
From €3174EUR$3,545USD£2,725GBP
€3526EUR$3,939USD£3,027GBP
- Report
- January 2026
- 196 Pages
Global
From €3174EUR$3,545USD£2,725GBP
€3526EUR$3,939USD£3,027GBP
- Report
- January 2026
- 184 Pages
Global
From €3174EUR$3,545USD£2,725GBP
€3526EUR$3,939USD£3,027GBP
- Report
- January 2026
- 193 Pages
Global
From €3174EUR$3,545USD£2,725GBP
€3526EUR$3,939USD£3,027GBP
- Report
- January 2026
- 182 Pages
Global
From €3174EUR$3,545USD£2,725GBP
€3526EUR$3,939USD£3,027GBP
- Report
- January 2026
- 195 Pages
Global
From €3174EUR$3,545USD£2,725GBP
€3526EUR$3,939USD£3,027GBP
- Report
- January 2026
- 197 Pages
Global
From €3174EUR$3,545USD£2,725GBP
€3526EUR$3,939USD£3,027GBP
- Report
- January 2026
- 197 Pages
Global
From €3174EUR$3,545USD£2,725GBP
€3526EUR$3,939USD£3,027GBP
- Report
- November 2025
- 199 Pages
Global
From €3174EUR$3,545USD£2,725GBP
€3526EUR$3,939USD£3,027GBP
- Report
- July 2026
- 194 Pages
Global
From €3174EUR$3,545USD£2,725GBP
€3526EUR$3,939USD£3,027GBP
- Report
- January 2026
- 197 Pages
Global
From €3174EUR$3,545USD£2,725GBP
€3526EUR$3,939USD£3,027GBP
- Report
- January 2026
- 194 Pages
Global
From €3174EUR$3,545USD£2,725GBP
€3526EUR$3,939USD£3,027GBP
- Report
- November 2025
- 189 Pages
Global
From €3174EUR$3,545USD£2,725GBP
€3526EUR$3,939USD£3,027GBP
- Report
- February 2026
- 250 Pages
Global
From €4020EUR$4,490USD£3,451GBP

The Oligonucleotide Synthesis market is a segment of the biotechnology industry that focuses on the production of short, single-stranded DNA or RNA molecules. These molecules are used in a variety of applications, such as gene therapy, drug discovery, and diagnostics. Oligonucleotides are synthesized using a variety of techniques, including phosphoramidite chemistry, phosphorothioate chemistry, and solid-phase synthesis.
The Oligonucleotide Synthesis market is driven by the increasing demand for gene therapy and personalized medicine. Additionally, the development of new technologies, such as next-generation sequencing, has enabled the production of more complex oligonucleotides.
Some of the major players in the Oligonucleotide Synthesis market include Thermo Fisher Scientific, Agilent Technologies, Merck KGaA, Eurofins Scientific, and Bio-Synthesis. Show Less Read more